Joyce O’Shaughnessy
- Oncology top 0.1%
- Cancer Research top 0.2%
- Pulmonary and Respiratory Medicine top 0.5%
- Molecular Biology top 5%
- Radiology, Nuclear Medicine and Imaging top 2%
- Co-authors
- William J. GradisharPaul BharNeil DesaiSergei TjulandinMichael HawkinsHeather ShawNeville DavidsonJohn Pippen
- Topics
- Cancer Treatment and Pharmacology (121 papers)Advanced Breast Cancer Therapies (108 papers)HER2/EGFR in Cancer Research (92 papers)
- Partner nations
- United StatesSpainUnited Kingdom
In The Last Decade
Joyce O’Shaughnessy
227 papers receiving 9.3k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Oncology 7.0k
- Cancer Research 3.1k
- Pulmonary and Respiratory Medicine 2.8k
- Molecular Biology 2.1k
- Radiology, Nuclear Medicine and Imaging 739
Countries citing papers authored by Joyce O’Shaughnessy
This map shows the geographic impact of Joyce O’Shaughnessy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joyce O’Shaughnessy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joyce O’Shaughnessy more than expected).
Fields of papers citing papers by Joyce O’Shaughnessy
This network shows the impact of papers produced by Joyce O’Shaughnessy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joyce O’Shaughnessy. The network helps show where Joyce O’Shaughnessy may publish in the future.
Co-authorship network of co-authors of Joyce O’Shaughnessy
This figure shows the co-authorship network connecting the top 25 collaborators of Joyce O’Shaughnessy. A scholar is included among the top collaborators of Joyce O’Shaughnessy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joyce O’Shaughnessy. Joyce O’Shaughnessy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522breakdown → | 47 |
| 3 | 9 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 33 | |
| 7 | 1 | |
| 8 | 8 | |
| 9 | 1 | |
| 10 | 49 | |
| 11 | 28 | |
| 12 | 8 | |
| 13 | 3 | |
| 14 | 74 | |
| 15 | 15 | |
| 16 | 9 | |
| 17 | MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2− Metastatic Breast Cancerbreakdown → | 490 |
| 18 | 37 | |
| 19 | Highlights in metastatic breast cancer From the 2012 San Antonio Breast Cancer Symposium (SABCS). | 2 |
| 20 | 400 |
About Joyce O’Shaughnessy
Joyce O’Shaughnessy is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 240 papers that have together received 9.6k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (121 papers), Advanced Breast Cancer Therapies (108 papers) and HER2/EGFR in Cancer Research (92 papers). The work is most often cited by research in Oncology (7.0k citations), Cancer Research (3.1k citations) and Pulmonary and Respiratory Medicine (2.8k citations). Joyce O’Shaughnessy has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include William J. Gradishar, Paul Bhar, Neil Desai, Sergei Tjulandin, Michael Hawkins, Heather Shaw, Neville Davidson, John Pippen, Denise A. Yardley and Véronique Dièras. Their work appears in journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.